Trials of Sanofi and Regeneron’s drug Dupixent (dupilumab) have shown positive results for treating patients suffering from chronic rhinosinusitis with nasal polyps, teeing up a potential new use.

Interleukins promote development and differentiation of natural killer ... but can have a treatment resistant neutrophilic phenotype. Here the authors characterise nasal polyps using single ...

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.

Certain medications can help shrink or stop the growth of nasal polyps. Your healthcare provider can help you determine the cause of your polyps and find the most appropriate treatment.